Removal of atrazine from aqueous solutions onto a magnetite/chitosan/activated carbon composite in a fixed-bed column system: optimization using response surface methodology.

In this study, a magnetite/chitosan/activated carbon (MCHAC) composite is proposed as an efficient adsorbent for the removal of atrazine from aqueous solutions. The prepared composite was characterized using Fourier-transform infrared (FTIR) and X-ray diffraction (XRD) methods. Response surface methodology (RSM) coupled with composite central design (CCD) were used to optimize the effects of the four independent variables, pH, initial concentration of atrazine (C 0), bed depth (H), and flow rate (Q), which influence the adsorption process. The experimental results modeled using response surface methodology (RSM) coupled with central composite design (CCD) (RSM-CCD) indicated a quadratic relationship with p < 0.0001 for adsorption capacity at saturation (q s) and fraction of bed utilization (FBU). The results of the experiments performed under the optimized conditions, pH = 5.07, C 0 = 137.86 mg L-1, H = 2.99 cm and Q = 1.038 mL min-1, showed a q s value of 62.32 mg g-1 and FBU of 72.26%, with a deviation value of less than 0.05 from the predicted q s and FBU values. The obtained breakthrough curves were fitted with four mathematical models, Thomas, Bohart-Adams, Yan and Yoon-Nelson, in order to determine the limiting step of the mass transfer of the atrazine adsorption onto the composite. A desorption study of the composite revealed the high reuse potential for MCHAC, thus, the prepared material could be used as a low-cost and efficient adsorbent for the decontamination of polluted wastewater.

Gadolinium oxysulfide nanoparticles as multimodal imaging agents for T2-weighted MR, X-ray tomography and photoluminescence.

We have synthesized gadolinium oxysulfide nanoparticles (NPs) doped with other lanthanides (Eu(3+), Er(3+), Yb(3+)) via a hydroxycarbonate precursor precipitation route followed by a sulfuration process under a H2S-Ar atmosphere at 750 °C in order to propose new multimodal nanoplatforms for Magnetic Resonance (MR), X-ray and photoluminescence imaging. Gd2O2S:Eu(3+) NPs strongly absorb near UV (≈ 300-400 nm) and re-emit strong red light (624 nm). They can be easily internalized by cancer cells, and imaged by epifluorescence microscopy under excitation in the NUV (365 nm). They are not cytotoxic for living cells up to 100 µg mL(-1). Consequently, they are well adapted for in vitro imaging on cell cultures. Gd2O2S:Eu(3+) NPs also show strong transverse relaxivity and strong X-ray absorption allowing their use as contrast agents for T2-weighted MRI and X-ray tomography. Our study shows that Gd2O2S:Eu(3+) NPs are considerably better than commercial Ferumoxtran-10 NPs as negative contrast agents for MRI. Upconversion emission of Gd2O2S:Er; Yb (1; 8%) NPs under infrared excitation (λ(ex) = 980 nm) shows mainly red emission (≈ 650-680 nm). Consequently, they are more specifically designed for in vivo deep fluorescence imaging, because both excitation and emission are located inside the "transparency window" of biological tissues (650-1200 nm). Magnetic relaxivity and X-ray absorption behaviors of Gd2O2S:Er; Yb NPs are almost similar to Gd2O2S:Eu(3+) NPs.